Compare TRN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRN | LMAT |
|---|---|---|
| Founded | 1933 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1994 | 2006 |
| Metric | TRN | LMAT |
|---|---|---|
| Price | $27.96 | $80.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $34.00 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 449.5K | 223.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.03% | 0.93% |
| EPS Growth | ★ 85.98 | 30.57 |
| EPS | ★ 1.50 | 1.42 |
| Revenue | ★ $2,156,900,000.00 | $249,602,000.00 |
| Revenue This Year | $1.91 | $14.21 |
| Revenue Next Year | $15.61 | $8.88 |
| P/E Ratio | ★ $18.59 | $55.77 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $24.76 | $78.22 |
| 52 Week High | $38.31 | $118.01 |
| Indicator | TRN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 39.33 | 42.17 |
| Support Level | $27.53 | $78.65 |
| Resistance Level | $28.89 | $82.45 |
| Average True Range (ATR) | 0.54 | 1.68 |
| MACD | 0.16 | 0.45 |
| Stochastic Oscillator | 46.56 | 37.42 |
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.